thus far
[161] There was low- to moderate-strength evidence of no benefit for most of the other medications used in RCTs, which included antidepressants (bupropion, mirtazapine, sertraline), antipsychotics (aripiprazole), anticonvulsants (topiramate, baclofen, gabapentin), naltrexone, varenicline, citicoline, ondansetron, prometa, riluzole, atomoxetine, dextroamphetamine, and modafinil
J., Pattee G
Sometimes due diligence is not done regarding the safety or efficacy of what is being recommended, she said
This interpretation is consistent with clinical observations that oral glutathione supplementation has limited bioavailability, favoring approaches that maintain precursor sufficiency instead of direct replacement [117,118,119]
Extracellular vesicles as an alternative copper-secretion mechanism in bacteria